March 03, 2015 6:32 PM ET


Company Overview of Protherics plc

Company Overview

As of December 4, 2008,Protherics PLC was acquired by BTG plc. Protherics PLC, a biopharmaceutical company, focuses on the development, manufacture, and marketing of specialized hospital products for critical care and cancer primarily in the United Kingdom, the United States, and Australia. The company offers various products for application in medical emergencies, such as overdose, poisoning, and life-threatening infections. It offers critical care products, which include CroFab, a polyclonal antibody fragment that neutralizes venom from North American Crotalid snakes; DigiFab, a polyclonal antibody fragment for the treatment of life-threatening digoxin toxicity or overdose; CytoFab, which ...

The Heath Business and Technical Park

Runcorn,  WA7 4QX

United Kingdom

303 Employees


44 19 2851 8000


44 19 2851 8002

Key Executives for Protherics plc

Protherics plc does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
TeleMedicine International PLC Europe
Biogen Idec Ltd. Europe
Endocrine Pharmaceuticals Limited Europe
Takeda Cambridge Limited Europe
Serono Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Protherics plc, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at